Concepedia
Statistics
Publications
3
Citations
90
H-Index
Active since
2014
Affiliations
Dana-Farber Cancer Institute(Current)
The University of Texas MD Anderson Cancer Center
Ana Korngold is an author at Dana-Farber Cancer Institute.
Publications per year
2014–2023
Ameli-01: A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia (AML)
David A. Sallman, Daniel J. DeAngelo, Naveen Pemmaraju et al. · Blood · 2022 · 60 citations
Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers
Raimundo Coutinho, Maria Fernanda Rios Grassi, Ana Korngold et al. · BMC Infectious Diseases · 2014 · 16 citations · Full text
Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T Cell Product Manufactured By Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nitin Jain, Patrice Chevallier, Hongtao Liu et al. · Blood · 2023 · 14 citations
1–3 of 3